GSK, Sanofi to agree $624 million deal with UK for COVID-19 vaccine
Both GSK and Sanofi said that they are placing more priority on quality rather than speed.
Both GSK and Sanofi said that they are placing more priority on quality rather than speed.
The Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (GSK), has appointed a new Managing Director (MD).
On Thursday, May 24th during its 47th Annual General Meeting, shareholders of GlaxoSmithKline Consumer Nigeria Plc approved the declared special dividend ...
Glaxo Smithkline Consumer Nigeria Plc today released its financial statements for the period ended Q1 March 31st 2018. Here are ...
Following the resignation of its Managing Director, Dayanand Thandalam Sriram, GlaxoSmithKline Consumer Nigeria Plc, GSK, has announced the appointment of Bhushan ...